首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical cardiology

缩写:CLIN CARDIOL

ISSN:0160-9289

e-ISSN:1932-8737

IF/分区:2.8/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引3254条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Pingwei Liu,Guangsheng Cai,Yanmei Wang et al. Pingwei Liu et al.
Background: Early dual antiplatelet therapy (DAPT) improves outcomes in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). Although guidelines recommend prompt...
Xiaofeng Peng,Ting Guo,Xiuzheng Wang et al. Xiaofeng Peng et al.
Aims: This study systematically examined the multilevel determinants influencing 24 h movement behaviors (physical activity, sedentary behavior, and sleep) in coronary heart disease patients on the basis of a socioecologi...
Taha Alam,Sohaima Kamal,Dhvanit Rajdeep et al. Taha Alam et al.
Background: Ischemic heart disease (IHD) remains a leading cause of mortality in the United States, while arrhythmia-related deaths are increasing. However, long-term mortality trends involving both conditions remain uncl...
Weiping Xiao,Zhiyan Wang,Di-En Yan et al. Weiping Xiao et al.
Background: Urinary albumin-to-creatinine ratio (uACR) is a recognized cardiovascular risk marker, but its dynamic changes in heart failure with preserved ejection fraction (HFpEF) remain underexplored. We aimed to identi...
Weiping Xiao,Zhiyan Wang,Di-En Yan et al. Weiping Xiao et al.
Background: Urinary albumin-to-creatinine ratio (uACR) is a recognized cardiovascular risk marker, but its dynamic changes in heart failure with preserved ejection fraction (HFpEF) remain underexplored. We aimed to identi...
Weiping Xiao,Zhiyan Wang,Di-En Yan et al. Weiping Xiao et al.
Background: Urinary albumin-to-creatinine ratio (uACR) is a recognized cardiovascular risk marker, but its dynamic changes in heart failure with preserved ejection fraction (HFpEF) remain underexplored. We aimed to identi...
Ibrahim Khalil,Md Imran Hossain,Mst Mahmuda Akter et al. Ibrahim Khalil et al.
Background: No direct head-to-head trials compare tirzepatide and dulaglutide in heart failure with preserved ejection fraction (HFpEF), though tirzepatide shows superior weight loss and potential cardiovascular benefits ...
Ibrahim Khalil,Md Imran Hossain,Mst Mahmuda Akter et al. Ibrahim Khalil et al.
Background: No direct head-to-head trials compare tirzepatide and dulaglutide in heart failure with preserved ejection fraction (HFpEF), though tirzepatide shows superior weight loss and potential cardiovascular benefits ...